Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

658 results found

Article
Ask Lexy

HFW | European Union, United Kingdom | 24 Nov 2023

CMA publishes provisional decision not to replace the Retained Liner Consortia Block Exemption Regulation

On 17 November 2023, the UK Competition and Markets Authority (CMA) published for consultation its provisional decision on the replacement of the…
Article
Ask Lexy

DLA Piper | United Kingdom | 23 Nov 2023

UK CMA publishes Competition Law Guidance for Cooperations on Combination Therapies

Combination therapies involve the use of two or more separate medicines in combination to treat a disease. It can be compromised of a 'backbone'…
Article
Ask Lexy

Herbert Smith Freehills LLP | United Kingdom | 23 Nov 2023

CMA issues guidance permitting drugs companies to work together on Combination Therapies

On 17 November 2023, the CMA issued a Prioritisation Statement (the Statement) indicating that it would not prioritise investigations under Chapter I…
Article
Ask Lexy

Herbert Smith Freehills LLP | United Kingdom | 22 Nov 2023

Revised litigation funding agreement approved for opt-out competition claim: fee based on multiple of funding was not a DBA

The Competition Appeal Tribunal (CAT) has found that a litigation funding agreement that was revised to take account of the Supreme Court’s decision…
Analysis PRO In-house
Ask Lexy

Lexology PRO | European Union, Portugal, United Kingdom | 21 Nov 2023

CAT provisionally certifies class action against Sony

Sony has failed to stop a £5 billion opt-out damages claim brought on behalf of nine million consumers, although the UK’s Competition Appeal Tribunal has ordered the class representative to amend the defined class.
Article
Ask Lexy

Macfarlanes LLP | United Kingdom | 21 Nov 2023

A dose of legal certainty: CMA’s Prioritisation Statement provides guidance for co-operation between suppliers of combination therapies

The Competition and Markets Authority (CMA) published a Prioritisation statement on combination therapies on 17 November 2023 (the Prioritisation…
Article
Ask Lexy

RPC | European Union, United Kingdom | 17 Nov 2023

Regulatory update - November 2023

Welcome to the latest edition of our bi-monthly Regulatory update, which pulls together recent developments from across the UK’s regulators. As…
Article
Ask Lexy

Brodies LLP | United Kingdom | 15 Nov 2023

CMA publishes new guidance on 'Green Agreements'

The Competition and Markets Authority (CMA) has published new guidance on how it will approach 'green agreements'. It aims to give greater clarity to…
Article
Ask Lexy

Hausfeld LLP | United Kingdom | 15 Nov 2023

One size fits one? The challenge of “tailored” regulation in digital markets in the UK

It is perhaps not entirely surprising, given intervening events, that it took the UK government close to four years from the publication in July 2019…
Article
Ask Lexy

Morgan, Lewis & Bockius LLP | United Kingdom | 14 Nov 2023

UK Competition and Markets Authority Launches Investigation Into Cloud Services Market

Following the UK Office of Communications’ (Ofcom’s) report on the supply of cloud services in the United Kingdom, in which it identified a concern…
Previous page 1 2 3 ...